ENTRY       D00440                      Drug
NAME        Nizatidine (JP18/USP/INN);
            Acinon (TN);
            Axid (TN)
PRODUCT
  GENERIC   NIZATIDINE (Actavis Pharma)
            NIZATIDINE (Amneal Pharmaceuticals LLC)
            NIZATIDINE (Dr Reddy's Laboratories Limited)
            NIZATIDINE (Glenmark Pharmaceuticals)
            NIZATIDINE (Proficient Rx LP)
FORMULA     C12H21N5O2S2
EXACT_MASS  331.1137
MOL_WEIGHT  331.4574
CLASS       Gastrointestinal agent
             DG01975  Agents for peptic ulcer
              DG01481  Histamine receptor H2 antagonist
REMARK      Same as: C07270
            Therapeutic category: 2325
            ATC code: A02BA04
            Product: D00440<JP/US>
EFFICACY    Anti-ulcerative, H2 receptor antagonist
  DISEASE   Duodenal ulcer [DS:H01634]
            GERD [DS:H01602]
            Gastric ulcer [DS:H01634]
TARGET      HRH2 [HSA:3274] [KO:K04150]
  PATHWAY   hsa04020(3274)  Calcium signaling pathway
            hsa04080(3274)  Neuroactive ligand-receptor interaction
            hsa04971(3274)  Gastric acid secretion
INTERACTION  
STR_MAP     map07038  Antiulcer drugs
            map07227  Histamine H2/H3 receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A02 DRUGS FOR ACID RELATED DISORDERS
               A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
                A02BA H2-receptor antagonists
                 A02BA04 Nizatidine
                  D00440  Nizatidine (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Gastrointestinal Agents
              Histamine2 (H2) Receptor Antagonists
               Nizatidine
                D00440  Nizatidine (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               232  Peptic ulcer agents
                2325  H2 blockers
                 D00440  Nizatidine (JP18/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for digestive organs
              09 Histamine H2 receptor blocker containing drugs
               D00440  Nizatidine (JP18/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             First-class OTC drugs
              Inorganic and organic chemicals
               Nizatidine
                D00440  Nizatidine (JP18/USP/INN)
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01975  Agents for peptic ulcer
               DG01481  Histamine receptor H2 antagonist
                D00440  Nizatidine
            Drug classes [BR:br08332]
             Gastrointestinal agent
              DG01481  Histamine receptor H2 antagonist
               D00440  Nizatidine
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Histamine
                HRH2
                 D00440  Nizatidine (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00440  Nizatidine
              D00440  Nizatidine capsules
            Rx-to-OTC switch list in the USA [br08315.html]
             D00440
            Rx-to-OTC switch list in Japan [br08314.html]
             D00440
DBLINKS     CAS: 76963-41-2
            PubChem: 7847506
            ChEBI: 7601
            LigandBox: D00440
            NIKKAJI: J32.887A
ATOM        21
            1   C1b C    21.6127  -25.2508
            2   S2a S    22.8717  -24.5514
            3   C1b C    24.0608  -25.2508
            4   C1b C    25.2498  -24.5514
            5   N1b N    26.5088  -25.2508
            6   C2c C    27.6979  -24.5514
            7   C8y C    20.4236  -24.5514
            8   N5x N    20.4236  -23.1525
            9   C8y C    19.0946  -22.7328
            10  S2x S    18.2553  -23.8519
            11  C8x C    19.0946  -24.9710
            12  C1b C    18.6750  -21.4038
            13  C2b C    28.9569  -25.2508
            14  N1c N    17.3091  -21.1017
            15  C1a C    16.3385  -22.1622
            16  C1a C    16.8910  -19.7792
            17  N2b N    30.1567  -24.5315 #+
            18  O3a O    31.3796  -25.2108
            19  O3a O    30.1338  -23.1526 #-
            20  N1b N    27.7512  -23.1705
            21  C1a C    26.5443  -22.4100
BOND        21
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     1   7 1
            7     7   8 1
            8     8   9 2
            9     9  10 1
            10   10  11 1
            11    7  11 2
            12    9  12 1
            13    6  13 2
            14   12  14 1
            15   14  15 1
            16   14  16 1
            17   13  17 1
            18   17  18 2
            19   17  19 1
            20    6  20 1
            21   20  21 1
///
